Substitution Fee Sample Clauses

Substitution Fee. OncoGenex will pay Isis (i) [***] plus (ii) the applicable Target Level Fee (as calculated under Section 4.1 above) for such target for each substituted Collaboration Gene Target it makes under Section 2.3.3 (a “Substitution Fee”); provided however that OncoGenex may credit the Target Level Fee OncoGenex paid to Isis (if any) for the Collaboration Gene Target replaced as part of such substitution against this substitution fee. Notwithstanding the foregoing, OncoGenex will not receive any refund or reimbursement if the amount OncoGenex is entitled to credit under this Section 4.2 is greater than the applicable Substitution Fee. The payments due Isis under this Section are payable in cash or shares of OncoGenex Preferred Stock (as defined in Appendix 1) at OncoGenex’s sole discretion.
Sample 1Sample 2
AutoNDA by SimpleDocs
Substitution Fee. In the event that the Borrowers request a Substitution, the Borrowers shall pay to the Facility Agent (for distribution pro rata to the Lenders) a substitution fee equal to 15 bps of the Tranche relating to the Substitution Vessel within five (5) days from the Substitution Date.
Sample 1Sample 2
Substitution Fee. In the event CRISPR choses to substitute the [*****] Program a Substitution Fee of [*****] US dollars (US$ [*****]) is due within [*****] days of confirmation of the new target by CureVac, or once the target is confirmed not to be a Reserved Program in accordance with Section 4.3(b) above.
Sample 1Sample 2
Substitution Fee. If Lender consents to the addition of the proposed Substitute Mortgaged Property to the Collateral Pool, and Borrower elects to add the Substitute Mortgaged Property to the Collateral Pool, Borrower shall pay the Substitution Fee to Lender as one of the conditions to the closing of the Substitute Mortgaged Property.
Sample 1Sample 2
Substitution Fee. If Lender consents to the addition of the proposed Substitute Mortgaged Property to the Collateral Pool and the release of the proposed Release Property from the Collateral Pool, and Borrower elects to add the Substitute Mortgaged Property to the Collateral Pool and release the proposed Release Property from the Collateral Pool, Borrower shall pay the Substitution Fee and all legal fees and expenses payable by Borrower pursuant to Section 10.04 as one of the conditions to the closing of the addition of the Substitute Mortgaged Property to the Collateral Pool and the release of the proposed Release Property from the Collateral Pool.]
Sample 1
Substitution Fee. 7.2.1 During the Initial Collaboration Target Substitution Period, Merck shall have the right to substitute the Initial Collaboration Target in accordance with Section 4.1.3(a) a total of . During the first of the Initial Target Substitution Period (the “Initial Collaboration Target No-Cost Substitution Period”), Merck may make such substitutions at no cost. Following the Initial Collaboration Target No-Cost Substitution Period (during the remainder of the Initial Collaboration Target Substitution Period), to substitute the Initial Collaboration Target or the Substitute Collaboration Target substituting the Initial Collaboration Target in accordance with Section 4.1.3(a), Merck shall pay C4T a substitution fee as described below: Period # Period Start Date Period End Date Duration (in months) Event Determining Payment Amount Amount Due by Merck
Sample 1
Substitution Fee. The Substitute Financier agrees to pay the Facility Agent a fee of A$1500 on entering into the Substitution Agreement after the end of general syndication (as determined by the Facility Agent).
Sample 1
AutoNDA by SimpleDocs
Substitution Fee. Borrower shall pay to Lender on the Closing Date for a Substitution Request, a Substitution Fee.
Sample 1

Related to Substitution Fee

  • Distribution Fee In addition to the Service Fee, the Trust, on behalf of the Series, will pay to the Distributor a fee (the "Distribution Fee") at an annual rate of 0.75% (unless reduced as contemplated by and permitted pursuant to the next sentence hereof) of the Series' average daily net assets attributable to the Class B shares in consideration of the services rendered in connection with the sale of such shares by the Distributor. The Trust will not terminate the Distribution Fee in respect of Series assets attributable to Class B shares, or pay such fee at an annual rate of less than 0.75% of the Series' average daily net assets attributable to the Class B shares, unless it has ceased, and not resumed, paying the Service Fee (or any other fee that constitutes a "service fee" as defined in the NASD Rule) to CDC IXIS Distributors (or to any affiliate of CDC IXIS Distributors, or to any other person in circumstances where substantially all of the services and functions relating to the distribution of Class B shares of the Series have been delegated to, or are being performed by, CDC IXIS Distributors or an affiliate of CDC IXIS Distributors). Subject to such restriction and subject to the provisions of Section 7 hereof, the Distribution Fee shall be as approved from time to time by (a) the Trustees of the Trust and (b) the Independent Trustees of the Trust. The Distribution Fee shall be accrued daily and paid monthly or at such other intervals as the Trustees shall determine. The obligation of the Series to pay the Distribution Fee shall terminate upon the termination of this Plan or the relevant distribution agreement between the Distributor and the Trust relating to the Series, in accordance with the terms hereof or thereof, but until any such termination shall not be subject to any dispute, offset, counterclaim or defense whatsoever (it being understood that nothing in this sentence shall be deemed a waiver by the Trust or the Series of its right separately to pursue any claims it may have against the Distributor and enforce such claims against any assets of the Distributor (other than its right to be paid the Distribution Fee and to be paid contingent deferred sales charges)). The right of CDC IXIS Distributors to receive the Distribution Fee (but not the relevant distribution agreement or CDC IXIS Distributor's obligations thereunder) may be transferred by CDC IXIS Distributors in order to raise funds which may be useful or necessary to perform its duties as principal underwriter, and any such transfer shall be effective upon written notice from CDC IXIS Distributors to the Trust. In connection with the foregoing, the Series is authorized to pay all or part of the Distribution Fee directly to such transferee as directed by CDC IXIS Distributors. The Distributor may pay all or any portion of the Distribution Fee to securities dealers or other organizations (including, but not limited to, any affiliate of the Distributor) as commissions, asset-based sales charges or other compensation with respect to the sale of Class B shares of the Series, and may retain all or any portion of the Distribution Fee as compensation for the Distributor's services as principal underwriter of the Class B shares of the Series. All payments under this Section 2 are intended to qualify as "asset-based sales charges" as defined in the NASD Rule.

  • Loan Fee Borrower agrees to pay Lender a single loan fee per Loan (a “Loan Fee”) equal to $0.001 per Loaned Share. The Loan Fee shall be paid by Borrower on or before the time of transfer of the Loaned Shares pursuant to Section 2(d) on a delivery-versus-payment basis through the facilities of the Clearing Organization.

  • Origination Fee The Borrower shall pay the Lender a fully earned and non-refundable origination fee of $50,000, due and payable upon the execution of this Agreement.

  • Modification Fee In consideration of the Lenders amending the Loan Agreement as provided herein, each Borrower jointly and severally agrees to pay to the Agent for the account of each Lender approving this Amendment (which approval is evidenced by its signature below) a modification fee in an amount equal to one-half of one percent (0.50%) of such Lender’s Commitment.

  • Construction Fee A fee or other remuneration for acting as general contractor and/or construction manager to construct improvements, supervise and coordinate projects or to provide major repairs or rehabilitations on a Property.

  • Acquisition Fee Subject to Section 12(b), the Company shall pay an Acquisition Fee to the Advisor or its assigns as compensation for services rendered in connection with the investigation, selection and acquisition (by purchase, investment or exchange) of each Investment. If the Advisor is terminated without Cause pursuant to Section 18(b)(1), the Advisor or its assigns shall be entitled to an Acquisition Fee for any Investments acquired after the Termination Date for which a contract to acquire the applicable Investment had been entered into at or prior to the Termination Date. The total Acquisition Fee payable to the Advisor or its assigns shall be equal to 1.5% of (1) the Contract Purchase Price of each Investment and (2) the amount advanced for a Loan or other investment. The purchase price allocable for an Investment held through a Joint Venture shall equal the product of (i) the Contract Purchase Price of the Investment, multiplied by (ii) the direct or indirect ownership percentage in the Joint Venture held directly or indirectly by the Company or the Operating Partnership. For purposes of this Section 11(a), “ownership percentage” shall be the percentage of capital stock, membership interests, partnership interests or other equity interests owned directly or indirectly by the Company or the Operating Partnership, without regard to classification of such equity interests. The Company shall pay any Acquisition Fee due hereunder promptly upon the closing of the Investment. In addition, if during the period ending two years after the close of the initial Primary Offering, the Company sells an Investment and then reinvests the net proceeds in a new Investment(s), the Company shall pay to the Advisor or its assigns 1.0% of the Contract Purchase Price of the new Investment(s).

  • Financing Fee In the event of any debt financing obtained by or for the Company, the Company will pay to the Advisor or its assignees upon the closing of such debt financing a fee (a “Financing Fee”) equal to (i) 0.75% of the amount available under such debt financing, whether at the Company, Partnership, or any direct or indirect subsidiary level, and (ii) 0.75% of the portion that is attributable to the Company’s or the Partnership’s direct or indirect investment in a Joint Venture or partnership in which the Company or the Partnership is, directly or indirectly, a co-venturer or partner. The Advisor (or Sub-advisor) may reallow all or a portion of any Financing Fee to reimburse a non-Affiliated third party with whom it may subcontract to procure any such debt financing. All or any portion of the Financing Fees not taken as to any fiscal year shall be deferred without interest and may be paid in such other fiscal year as the Advisor shall determine.

  • Option Fee On the date hereof, Purchaser agrees to deliver to Owner the sum of One Thousand ($1,000.00) (the "Option Fee"). In the event that Purchaser exercises the Option, the Option Fee shall not be applied to the purchase price of the Premises. If Purchaser does not exercise the Option, Owner shall retain the Option Fee.

  • Extension Fee If the Borrower exercises its right to extend the Termination Date in accordance with Section 2.12., the Borrower agrees to pay to the Agent for the account of each Lender a fee equal to two-tenths of one percent (0.20%) of the amount of such Lender’s Commitment (whether or not utilized) at the time of such extension. Such fee shall be due and payable in full on the date the Agent receives the Extension Request pursuant to such Section.

  • Cancellation Fee to any person surrendering ADSs for cancellation and withdrawal of Deposited Securities or to any person to whom Deposited Securities are delivered, a fee not in excess of U.S. $5.00 per 100 ADSs (or fraction thereof) surrendered;

Time is Money Join Law Insider Premium to draft better contracts faster.